Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Review of ADHD pharmacotherapies: advantages, disadvantages, and clinical pearls.

× No keyword cloud information.

17 in total

1. Child attention deficit hyperactive disorder co morbidities on family stress: effect of medication.

Authors: Desiree Silva; Stephen Houghton; Erika Hagemann; Peter Jacoby; Brad Jongeling; Carol Bower
Journal: Community Ment Health J Date: 2014-08-26

Review 2. Current State and Model for Development of Technology-Based Care for Attention Deficit Hyperactivity Disorder.

Authors: Songpoom Benyakorn; Steven J Riley; Catrina A Calub; Julie B Schweitzer
Journal: Telemed J E Health Date: 2016-03-17 Impact factor: 3.536

3. Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts.

Authors: Mark A Stein; Irwin D Waldman; Elizabeth Charney; Subhash Aryal; Craig Sable; Reut Gruber; Jeffrey H Newcorn
Journal: J Child Adolesc Psychopharmacol Date: 2011-12-02 Impact factor: 2.576

4. One-year prospective follow-up of pharmacological treatment in children with attention-deficit/hyperactivity disorder.

Authors: Anna Didoni; Marco Sequi; Pietro Panei; Maurizio Bonati
Journal: Eur J Clin Pharmacol Date: 2011-05-03 Impact factor: 2.953

5. A randomized controlled trial investigation of a non-stimulant in attention deficit hyperactivity disorder (ACTION): rationale and design.

Authors: Tracey W Tsang; Michael R Kohn; Daniel F Hermens; Simon D Clarke; C Richard Clark; Daryl Efron; Noel Cranswick; Chris Lamb; Leanne M Williams
Journal: Trials Date: 2011-03-13 Impact factor: 2.279

10. Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder. Systematic review of review papers 2009-2011. An update for clinicians.

Authors: Chris J Bushe; Nicola Savill
Journal: J Cent Nerv Syst Dis Date: 2011-12-05

Review of ADHD pharmacotherapies: advantages, disadvantages, and clinical pearls.

1. Child attention deficit hyperactive disorder co morbidities on family stress: effect of medication.

Review 2. Current State and Model for Development of Technology-Based Care for Attention Deficit Hyperactivity Disorder.

3. Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts.

4. One-year prospective follow-up of pharmacological treatment in children with attention-deficit/hyperactivity disorder.

5. A randomized controlled trial investigation of a non-stimulant in attention deficit hyperactivity disorder (ACTION): rationale and design.

6. ADHD in international adoptees: a national cohort study.

7. Update on optimal use of lisdexamfetamine in the treatment of ADHD.

Review 8. Advances in understanding and treating ADHD.

9. Blood pressure in children with attention deficit/hyperactivity disorder.

10. Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder. Systematic review of review papers 2009-2011. An update for clinicians.